Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) on the safety of the mpox vaccines for use in at HealthBulance.

Health care is our expertise. In July 2022, WHO Director-General declared a Public Health Emergency of International Concern (PHEIC) in response to a multi-country outbreak of mpox that was rapidly spreading, mainly through sexual contact, in countries where it had not previously been detected.

WHO Org

Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) on the safety of the mpox vaccines for use in high-risk groups

Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) on the safety of the mpox vaccines for use in high-risk groups

In July 2022, WHO Director-General declared a Public Health Emergency of International Concern (PHEIC) in response to a multi-country outbreak of mpox that was rapidly spreading, mainly through sexual contact, in countries where it had not previously been detected. This PHEIC was lifted in May 2023 following a sustained global decline in cases. The emergence of the new Clade Ib and a resurgence of mpox cases in the African region led to the WHO declaration of a PHEIC again on 14 August 2024. The current outbreak in affected African countries also includes other high-risk groups such as pregnant women and children under the age of 18 years, including infants.